Table 2 The results of the univariate analysis of the associations between the serum soluble N-cadherin levels and the clinicopathological variables
From: Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors
Clinicopathological valiables | No of patients | Soluble N-cadherin (ng/ml) | p Value |
|---|---|---|---|
Bone tumor | 23 | 1,281 (560–2,575) | 0.8914 |
Soft tissue tumor | 50 | 1,264 (360–2,860) | |
Age (years) | 0.4665 | ||
≦49 | 32 | 1,232 (525–2,860) | |
≧50 | 41 | 1,298 (360–2,580) | |
Tumor size 1 | 0.0362 | ||
<5 cm | 17 | 1,025 (360–1,900) | |
≧5 cm | 56 | 1,343 (360–2,860) | |
Depth 2 | 0.5402 | ||
Superficial | 6 | 1,364 (390–2,180) | |
Deep | 67 | 1,261 (360–2,860) | |
Histological grading | 0.0482 | ||
Low grade | 14 | 1,050 (540–2,575) | |
High grade | 59 | 1,321 (360–2,860) | |
Primary tumor | 51 | 1,246 (360–2,860) | 0.4819 |
Recurrent / metastatic tumor | 22 | 1,323 (390–2,575) |